• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® HYBRID VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® HYBRID VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number 0650HYB0610
Device Problems Sticking (1597); Activation, Positioning or Separation Problem (2906)
Patient Problem Tissue Damage (2104)
Event Date 11/03/2015
Event Type  Injury  
Manufacturer Narrative
Lot: 13687094 (b)(4).Concomitant medical products: 11/03/15 gore® hybrid vascular graft lot #12745252 a review of the manufacturing records for the devices verified that the lots met all pre-release specifications.The devices were returned to w.L.Gore & associates for investigation.Submitted in this event was/were 2 incomplete gore® hybrid vascular grafts.The examination found no definitive anomalies attributable to the manufacture of the devices.The returned devices match the reported description of the devices in the event.Information provided reported the use of a ¿12fr.Peel away sheath¿ used for both grafts.Instructions for use (ifu) table 1 recommends use of an 11 fr peal/tear-away sheath size for a labeled nitinol reinforced section diameter of 6mm.Device 2: the deployment line not releasing from the nitinol reinforced section, in the observed position, is consistent with a device that has a re-positioned (deployment line looped over distal end) deployment line prior to deployment.
 
Event Description
On (b)(6) 2015, a patient was being implanted with two gore® hybrid vascular grafts in a debranching procedure in the superior mesenteric artery and the left renal artery.The grafts were both inserted through a 12 fr peel-away sheath.It was reported to gore that as the nitinol portion of the first device was being deployed into the superior mesenteric artery, the deployment line broke.The device was partially deployed.The arteriotomy was extended, the nitinol portion was removed and a regular anastomosis was performed.It was reported to gore that as the nitinol portion of the second device was being deployed into the renal artery, the deployment line got stuck after two-thirds of the device deployed.The procedure was completed by extending the arteriotomy, cutting the nitinol portion off and performing a regular anastomosis.
 
Manufacturer Narrative
Corrected data: complainant was a distributor.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® HYBRID VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
sandra whicker
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5308454
MDR Text Key33835182
Report Number2017233-2015-00896
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeIS
PMA/PMN Number
K093934
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/21/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/18/2018
Device Catalogue Number0650HYB0610
Device Lot Number13687094
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/30/2015
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/17/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/21/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/11/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age58 YR
-
-